All news

COO exercises options and sells 35,643 shares in Adaptive Biotechnologies (ADPT).

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Adaptive Biotechnologies' President and COO, Julie Rubinstein, exercised options for 35,643 common shares at an exercise price of

Read original source

ADPT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.